WO2005098440A3 - Methods for identifying agents useful for the treatment of neurodegenerative diseases - Google Patents

Methods for identifying agents useful for the treatment of neurodegenerative diseases Download PDF

Info

Publication number
WO2005098440A3
WO2005098440A3 PCT/US2005/009731 US2005009731W WO2005098440A3 WO 2005098440 A3 WO2005098440 A3 WO 2005098440A3 US 2005009731 W US2005009731 W US 2005009731W WO 2005098440 A3 WO2005098440 A3 WO 2005098440A3
Authority
WO
WIPO (PCT)
Prior art keywords
neurodegenerative diseases
methods
treatment
identifying agents
disease
Prior art date
Application number
PCT/US2005/009731
Other languages
French (fr)
Other versions
WO2005098440A2 (en
Inventor
Kristina L Rhoades
Hongwen Ma
Flossie Wong-Staal
Original Assignee
Immusol Inc
Kristina L Rhoades
Hongwen Ma
Flossie Wong-Staal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immusol Inc, Kristina L Rhoades, Hongwen Ma, Flossie Wong-Staal filed Critical Immusol Inc
Publication of WO2005098440A2 publication Critical patent/WO2005098440A2/en
Publication of WO2005098440A3 publication Critical patent/WO2005098440A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease

Abstract

The present invention is directed to methods for identifying agents that are useful for the treatment of neurodegenerative diseases. Examples of such diseases include Alzheimer's disease, Parkinson's disease and Huntington's disease. The methods involve testing such agents against genes or proteins disclosed herein and ascertaining the degree of protection provided by such agents against induction of neuronal cell death. The use of such agents for treating neurodegenerative diseases is also described.
PCT/US2005/009731 2004-03-26 2005-03-23 Methods for identifying agents useful for the treatment of neurodegenerative diseases WO2005098440A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55704604P 2004-03-26 2004-03-26
US60/557,046 2004-03-26

Publications (2)

Publication Number Publication Date
WO2005098440A2 WO2005098440A2 (en) 2005-10-20
WO2005098440A3 true WO2005098440A3 (en) 2006-04-20

Family

ID=35125708

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/009731 WO2005098440A2 (en) 2004-03-26 2005-03-23 Methods for identifying agents useful for the treatment of neurodegenerative diseases

Country Status (1)

Country Link
WO (1) WO2005098440A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001075067A2 (en) * 2000-03-31 2001-10-11 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2002070539A2 (en) * 2001-03-05 2002-09-12 Hyseq, Inc. Novel nucleic acids and polypeptides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001075067A2 (en) * 2000-03-31 2001-10-11 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2002070539A2 (en) * 2001-03-05 2002-09-12 Hyseq, Inc. Novel nucleic acids and polypeptides

Also Published As

Publication number Publication date
WO2005098440A2 (en) 2005-10-20

Similar Documents

Publication Publication Date Title
NO20053855L (en) 1-Phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases.
WO2005003766A3 (en) Methods of regulating metabolism and mitochondrial function
WO2006001877A3 (en) Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
WO2006092668A3 (en) Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
WO2004076639A8 (en) Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus
WO2008016659A3 (en) Agents for treating neurodegenerative diseases
WO2008021210A3 (en) Methods and compositions for the treatment of neurodegenerative disorders
GB0421639D0 (en) Methods and compositions relating to alzheimer's disease
WO2009043159A8 (en) Neural tumor stem cells and methods of use thereof
WO2008106646A3 (en) Methods and formulations for topical gene therapy
WO2007109107A3 (en) Atf4 as a therapeutic target in alzheimers disease and other neurological disorders
WO2007119179A3 (en) Use of the ornithine transcarbamylase (otc), as a marker for diagnosing brain damages
WO2008034016A3 (en) Assays for detecting native-state proteins and identifying compounds that modulate the stability of native-state proteins
WO2006042137A3 (en) Methods for identifying parkinson's disease therapeutics
WO2006083797A3 (en) Improving and protecting cell therapy for neurological disorders including parkinson's disease
WO2004106495A3 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
WO2010011283A3 (en) Fus/tls-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseases
HUP0303900A2 (en) New use of artemin, a member of the gdnf ligand family
IL169889A0 (en) Methods for diagnosis and monitoring of neurological disease by detection of an encephalotoxin
WO2010041252A3 (en) Use of a cinnamon bark extract for treating amyloid-associated diseases
WO2007098047A3 (en) Methods and compositions for the treatment of parkinson's disease
ATE399758T1 (en) DERIVATIVES OF 1-PHENYLALKANECARBONIC ACIDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
WO2007017146A3 (en) Use of collismycin and derivatives thereof as oxidative stress inhibitors
IL167848A (en) Use of brimonidine in the manufacture of a medicament for treating neurodegenerative conditions
WO2009043858A3 (en) Methods for treating and diagnosing a cancer secreting cath-d or alzheimer's disease

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase in:

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase